Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)
China flag China · Delayed Price · Currency is CNY
6.94
+0.33 (4.99%)
May 21, 2026, 3:00 PM CST

SHA:605199 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
76.5778.21254.29522.69480.37487.68
Cash & Short-Term Investments
76.5778.21254.29522.69480.37487.68
Cash Growth
-52.75%-69.24%-51.35%8.81%-1.50%41.00%
Accounts Receivable
432.52426.72416.74469.77453.68355.42
Other Receivables
20.5320.232.816.32.924.18
Receivables
453.05446.95419.55476.06456.6359.6
Inventory
226.73254.34446.77280.5213.56213.23
Other Current Assets
96.86101.8198.8763.2896.7326.32
Total Current Assets
853.21881.31,2191,3431,2471,087
Property, Plant & Equipment
1,3961,4121,3821,263802.62529.36
Long-Term Investments
15.9116.6818.4220.4420.1-
Goodwill
--12.1112.11--
Other Intangible Assets
189.62192.05182160.05102.36113.99
Long-Term Deferred Tax Assets
10.3610.4213.568.335.18.12
Long-Term Deferred Charges
87.3186.6395.1887.8455.5522.63
Other Long-Term Assets
3.833.7641.8644.9579.08-
Total Assets
2,5562,6032,9652,9392,3121,761
Accounts Payable
555.68539.97404.37194.16139.9244.75
Accrued Expenses
39.8539.9141.8738.6548.16145.99
Short-Term Debt
427.01433.88411.32420.62500.95438.98
Current Portion of Long-Term Debt
105.43192.13262.17118.520.1352.08
Current Portion of Leases
--41.952.984.54.05
Current Income Taxes Payable
29.1526.981.199.42.131.28
Current Unearned Revenue
72.4974.88126.87120.42262.1866
Other Current Liabilities
134.06133.65148.33152.3398.9340.81
Total Current Liabilities
1,3641,4411,4381,0571,057793.95
Long-Term Debt
614.98545.4589.54737.43177.61-
Long-Term Leases
11.2293.812.070.794.1
Long-Term Unearned Revenue
111.61111.1696.9276.2361.532.36
Long-Term Deferred Tax Liabilities
2.132.212.742.95--
Other Long-Term Liabilities
33.1243.540.18---
Total Liabilities
2,1272,1452,2211,8761,297830.41
Common Stock
400.11400.11400.11400.11400.11400.11
Additional Paid-In Capital
290.56290.56290.56290.56290.56290.56
Retained Earnings
-307.14-278.189.59334.07323.21237.53
Comprehensive Income & Other
0.180.210.28---
Total Common Equity
383.71412.7700.551,0251,014928.21
Minority Interest
45.8445.3242.7338.991.382.32
Shareholders' Equity
429.55458.02743.281,0641,015930.52
Total Liabilities & Equity
2,5562,6032,9652,9392,3121,761
Total Debt
1,1481,1731,3991,282683.98499.21
Net Cash (Debt)
-1,072-1,094-1,145-758.92-203.61-11.53
Net Cash Per Share
-2.67-2.74-2.88-2.10-0.50-0.03
Filing Date Shares Outstanding
413.69475.13400.11400.11400.11400.11
Total Common Shares Outstanding
413.69475.13400.11400.11400.11400.11
Working Capital
-510.46-560.09-218.6285.45190.37292.88
Book Value Per Share
0.930.871.752.562.532.32
Tangible Book Value
194.09220.66506.45852.58911.53814.21
Tangible Book Value Per Share
0.470.461.272.132.282.03
Buildings
--905.07353.33318.42304.62
Machinery
--531.56306.73273.68273.15
Construction In Progress
--252.92873.63433.13149.69
Source: S&P Global Market Intelligence. Standard template. Financial Sources.